Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...

Jenna Scott said doctors chalked up her abdominal cramping to pregnancy symptoms or IBS. It took a year to get diagnosed with ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...

There is currently a trial at the National Institutes of Health involving a revolutionary new treatment for cancer called Tumor-Infiltrating Immunotherapy. It uses one’s own immune cells to fight ...

Compared with people born from 1941 through 1949, incidence rates of appendix cancer have more than tripled among people born ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

Knowing your family history and symptoms to watch for can help ensure the disease is diagnosed as soon as possible ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Several cancers are becoming more common in young adults, including testicular cancer, melanoma, and cervical cancer. Blood-related cancers like B-cell lymphomas and plasma cell neoplasms are also on ...